Doctor Felecia

“As a doctor, as a psychiatrist, I'm skeptical of introducing bias and making policies that are based on something that is more local. I work in San Francisco.

What I thought at the time was that the patients that I was seeing were patients who were already sick. They already had mental health symptoms. They already were vulnerable in a vulnerable place.

And AI came in, wrong place, wrong time, wrong technology, and it made everything worse. Unfortunately, I think I was wrong. So what now research is that's coming out right now is saying, or showing is that the AI can actually induce distortions in your thinking, whether or not you had the delusions in the first place.

It can make anxiety and OCD worse just by interacting with it. Based on how it access your emotional circuitry in your brain, it can put you in a vulnerable place. The framework that they're trying to understand, how this happens, is that you start with a chatbot as a tool.

You use that tool at work, you're writing e-mails, writing code. At some point down the line, it starts introducing an emotional conversation with you. It is sycophantic, it matches your tone, and it starts to open you up to share more context, more information about yourself, more personal things.”

Keith Sakata, MD

The Dark Side of AI Chatbots: Warning Signs, Risks, and Reality Subscribe: https://www.youtube.com/?sub_confirmation=1Artif...

🚨 Important Update for Georgia Medical Cannabis Stakeholders

The Georgia Medical Cannabis Society is sharing urgent guidance from our national affiliate, Americans for Safe Access, regarding the newly released memorandum:

State Preparedness for Federal Cannabis Regulation & Enforcement: Part 1
State Actions Needed to Preserve & Protect Patient Access Before the June 26, 2026 DEA Registration Deadline

This guidance is especially important for medical cannabis operators, dispensary directors, license holders, compliance teams, regulators, healthcare stakeholders, patient advocates, and state decision-makers.

ASA’s memorandum outlines immediate steps states should consider to help protect patient access and prepare medical cannabis businesses for the federal transition created under AG Order No. 6754-2026. This includes DEA registration readiness, medical-only supply chain protections, patient enrollment and education, licensee guidance, and addressing record barriers that may impact patients, workers, caregivers, owners, and legacy operators.

For Georgia, this is not just a policy conversation. This is about making sure patients are not left behind while businesses, regulators, and state leaders navigate a rapidly changing federal landscape.

As a Georgia-based medical cannabis patient advocacy organization and national affiliate of Americans for Safe Access , GMCS is committed to helping spread accurate, timely, patient-centered information so Georgia stakeholders can stay informed and prepared.

📌 Key date to pay attention to: June 26, 2026
📌 Who should review this: Dispensary directors, operators, compliance teams, policymakers, patient advocates, healthcare professionals, and anyone connected to Georgia’s medical cannabis access system.

Thank you to Americans for Safe Access for continuing to lead with urgency, clarity, and a patient-first framework.

Check Comments for link to download Brief.

Patients Over Profits ~ Always.
Built by Patients. Powered by Pressure.

Well done, ladies!

WNBA Removes Ma*****na From Banned Substances List And Sets Rules For Player Endorsements Of H**p CBD Products - Ma*****na Moment The WNBA has officially removed ma*****na from its prohibited substances list while also laying out rules for how players can invest in and promote cannabis companies. At the same time, however, the women’s basketball league is also adding several psychedelics to the list of banned drugs. As part ...

Big To***co purchased food companies, and brought their playbook with them to addict us.

Now, bad actors are doing the same thing in the cannabis industry with artificial colors, flavors and breeding for high THC potency only.

Big to***co uses cigarette playbook to help sell ultra-processed foods, journal reveals New issue of the American Journal of Public Health focuses on parallels between marketing for ci******es and UPFs

It makes sense that synthetic cannabinoids demonstrated the most shrinkage in certain cancers. They tend to be more potent and attach to receptors more tightly and for longer periods of time than botanical cannabinoids. In addition, their metabolites can behave similarly.

This is one reason why using them in prenatal cannabis exposure research can lead to bad outcomes.

Ma*****na Components Have 'Consistent' Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows - Ma*****na Moment Components of ma*****na show “consistent and statistically significant anti-tumor effects” in certain types of cancer, including glioblastoma and breast cancer, according to a new scientific review that also found cannabinoids seem to “enhance chemotherapy efficacy.” The research, published ...

🤰🌿 Cannabis Use in Pregnancy: Context, Evidence, and Clinical Reality

How should clinicians discuss cannabis use during pregnancy when the evidence is complex, evolving, and often influenced by stigma, policy, and research limitations?

This SCC resource examines the current scientific evidence, the role of the endocannabinoid system, harm reduction considerations, and the need for patient-centered conversations that are compassionate, evidence-based, and clinically practical.

The article highlights the importance of moving beyond simplistic messaging toward a more nuanced understanding of risk, uncertainty, and real-world patient experiences.

👏 Authors: Felecia Dawson, MD, ABOG
& SCC President Genester Wilson-King, MD, FACOG
🔍 Editor: Jahan Marcu, PhD

Read the full article: https://www.cannabisclinicians.org/2026/05/18/scc-media-response-cannabis-use-in-pregnancy-context-evidence-and-clinical-reality/

Yes, we need more meaningful research.

In the meantime, we need decriminalization, informed healthcare providers, and risk reduction now!

Cannabis Use in Pregnancy – Context, Evidence, and Clinical Reality - Society of Cannabis Clinicians Authored by Felecia Dawson, MD, ABOG and Genester Wilson-King, MD, FACOG Edited by Jahan Marcu, PhD In October 2025, the American College of Obstetricians and Gynecologists updated its guidance on...

And then there were three… to block the move from Schedule I to III.

State Attorneys General File Lawsuit To Block Trump Administration's Ma*****na Rescheduling Move - Ma*****na Moment Three Republican state attorneys general have filed a lawsuit challenging the federal cannabis rescheduling action announced by President Donald Trump’s Department of Justice last month. The filing from the attorneys general of Indiana, Nebraska and Louisiana claims that they will “show that thi...

“Researchers use rats to provide evidence that biases in the extension of helping behavior is a product of experience—not genetically ingrained.”

How rat behavior may inform our understanding of racism Imagine that you wake up in a small room with no doors. You quickly realize that there is no way out. Oh, shoot. Further, you see that there is another individual trapped in a small cylindrical Plexiglas container in the middle of this arena, with barely any room to move. You are not sure what the c...